Companies: 49,303 Total Market Cap: $131.11 T
K

Krka, d. d.

LJSE-KRKG
Pharmaceutical Preparations
Rank #2642
Market Cap $6.39 B
Volume 2,555
Price $209.10
Change (%) 1.08%
Country or region Slovenia Slovenia

Krka, d. d.'s latest marketcap:

$6.39 B

As of 05/25/2025, Krka, d. d.'s market capitalization has reached $6.39 B. According to our data, Krka, d. d. is the 2642th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.

Market Cap $6.39 B
Revenue (ttm) $2.21 B
Net Income (ttm) $466.25 M
Shares Out 30.58 M
EPS (ttm) $15.17
Forward PE 15.28
Ex-Dividend Date 07/22/2025
Earnings Date 05/15/2025
Market Cap Chart
Data Updated: 05/25/2025

Krka, d. d.'s yearly market capitalization.

Krka, d. d. has seen its market value grow from €2.86 B to €5.63 B since 2020, representing a total increase of 96.63% and an annual compound growth rate (CAGR) of 16.60%.
Date Market Cap Change (%)
05/25/2025 €5.63 B 31.67%
12/30/2024 €4.27 B 25.64%
12/29/2023 €3.40 B 19.08%
12/30/2022 €2.86 B -22.28%
12/30/2021 €3.68 B 28.44%
12/30/2020 €2.86 B

Company Profile

About Krka, d. d.

Krka, d. d. is a leading generic pharmaceutical company specializing in the development, production, and distribution of prescription pharmaceuticals, over-the-counter (OTC) products, and animal health solutions. Headquartered in Novo Mesto, Slovenia, the company operates across Europe and internationally.

Core Business Areas

  • Prescription Pharmaceuticals: Offers treatments for cardiovascular diseases, alimentary tract and metabolism disorders, central nervous system conditions, infections, oncology, and more.
  • Non-Prescription Products: Includes oral and pharyngeal care, cough and cold remedies, analgesics, nasal products, vitamins, digestive aids, and general healthcare items.
  • Animal Health Products: Provides antimicrobials, antiparasitics, disinfectants, vitamins, minerals, and analgesics for veterinary use.

Additional Services

Beyond pharmaceuticals, Krka also offers health resort and tourist services, enhancing its commitment to holistic well-being.

Founded in 1954, Krka has grown into a trusted name in the pharmaceutical industry, delivering high-quality healthcare solutions worldwide.

Frequently Asked Questions

As of 05/25/2025, Krka, d. d. (including the parent company, if applicable) has an estimated market capitalization of $6.39 B USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.

Krka, d. d. global market capitalization ranking is approximately 2642 as of 05/25/2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.

Stock Detail

Country or region Slovenia
Founded 1954
IPO Date n/a
Employees 11,308
CEO Jože Colaric
Sector
Industry Pharmaceutical Preparations
Address Šmarješka cesta 6
Novo Mesto, 8501
Slovenia
Website https://www.krka.biz